Rating History for Royalty Pharma (RPRX) by UBS

More Stocks Rated by UBS | Latest Ratings for RPRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/30/2026 Ashwani Verma Upgrade Buy
(Neutral)		 49.00
(38.00)		 40.41
(45.41)		 12.37% Details